United States Antivenom Market Report 2017

September 2017 | 103 pages | ID: UF07A93C3C4EN
QYResearch

Abstracts

In this report, the United States Antivenom market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antivenom in these regions, from 2012 to 2022 (forecast).

United States Antivenom market competition by top manufacturers/players, with Antivenom sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Summerland Serums (AU)
• Haffkine Bio Pharmaceutical
• MicroPharm
• CSL (AU)
• SAVP
• Flynn Pharma
• Serum

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Humans
• Animals

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antivenom for each application, including

• Monovalent
• Polyvalent

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antivenom Market Report 2017

1 ANTIVENOM OVERVIEW

1.1 Product Overview and Scope of Antivenom
1.2 Classification of Antivenom by Product Category
  1.2.1 United States Antivenom Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antivenom Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Humans
  1.2.4 Animals
1.3 United States Antivenom Market by Application/End Users
  1.3.1 United States Antivenom Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Monovalent
  1.3.3 Polyvalent
1.4 United States Antivenom Market by Region
  1.4.1 United States Antivenom Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antivenom Status and Prospect (2012-2022)
  1.4.3 Southwest Antivenom Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antivenom Status and Prospect (2012-2022)
  1.4.5 New England Antivenom Status and Prospect (2012-2022)
  1.4.6 The South Antivenom Status and Prospect (2012-2022)
  1.4.7 The Midwest Antivenom Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antivenom (2012-2022)
  1.5.1 United States Antivenom Sales and Growth Rate (2012-2022)
  1.5.2 United States Antivenom Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIVENOM MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antivenom Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antivenom Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antivenom Average Price by Players/Suppliers (2012-2017)
2.4 United States Antivenom Market Competitive Situation and Trends
  2.4.1 United States Antivenom Market Concentration Rate
  2.4.2 United States Antivenom Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antivenom Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIVENOM SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antivenom Sales and Market Share by Region (2012-2017)
3.2 United States Antivenom Revenue and Market Share by Region (2012-2017)
3.3 United States Antivenom Price by Region (2012-2017)

4 UNITED STATES ANTIVENOM SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antivenom Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antivenom Revenue and Market Share by Type (2012-2017)
4.3 United States Antivenom Price by Type (2012-2017)
4.4 United States Antivenom Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIVENOM SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antivenom Sales and Market Share by Application (2012-2017)
5.2 United States Antivenom Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIVENOM PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antivenom Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Summerland Serums (AU)
  6.2.2 Antivenom Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Summerland Serums (AU) Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Haffkine Bio Pharmaceutical
  6.3.2 Antivenom Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Haffkine Bio Pharmaceutical Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 MicroPharm
  6.4.2 Antivenom Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 MicroPharm Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CSL (AU)
  6.5.2 Antivenom Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CSL (AU) Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 SAVP
  6.6.2 Antivenom Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 SAVP Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Flynn Pharma
  6.7.2 Antivenom Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Flynn Pharma Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Serum
  6.8.2 Antivenom Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Serum Antivenom Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ANTIVENOM MANUFACTURING COST ANALYSIS

7.1 Antivenom Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antivenom

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antivenom Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antivenom Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIVENOM MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antivenom Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antivenom Sales Volume Forecast by Type (2017-2022)
11.3 United States Antivenom Sales Volume Forecast by Application (2017-2022)
11.4 United States Antivenom Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antivenom
Figure United States Antivenom Market Size (K Doses) by Type (2012-2022)
Figure United States Antivenom Sales Volume Market Share by Type (Product Category) in 2016
Figure Humans Product Picture
Figure Animals Product Picture
Figure United States Antivenom Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Antivenom by Application in 2016
Figure Monovalent Examples
Table Key Downstream Customer in Monovalent
Figure Polyvalent Examples
Table Key Downstream Customer in Polyvalent
Figure United States Antivenom Market Size (Million USD) by Region (2012-2022)
Figure The West Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antivenom Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antivenom Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Antivenom Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Antivenom Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antivenom Sales Share by Players/Suppliers
Figure 2017 United States Antivenom Sales Share by Players/Suppliers
Figure United States Antivenom Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antivenom Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antivenom Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antivenom Revenue Share by Players/Suppliers
Figure 2017 United States Antivenom Revenue Share by Players/Suppliers
Table United States Market Antivenom Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Antivenom Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Antivenom Market Share of Top 3 Players/Suppliers
Figure United States Antivenom Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antivenom Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antivenom Product Category
Table United States Antivenom Sales (K Doses) by Region (2012-2017)
Table United States Antivenom Sales Share by Region (2012-2017)
Figure United States Antivenom Sales Share by Region (2012-2017)
Figure United States Antivenom Sales Market Share by Region in 2016
Table United States Antivenom Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antivenom Revenue Share by Region (2012-2017)
Figure United States Antivenom Revenue Market Share by Region (2012-2017)
Figure United States Antivenom Revenue Market Share by Region in 2016
Table United States Antivenom Price (USD/Dose) by Region (2012-2017)
Table United States Antivenom Sales (K Doses) by Type (2012-2017)
Table United States Antivenom Sales Share by Type (2012-2017)
Figure United States Antivenom Sales Share by Type (2012-2017)
Figure United States Antivenom Sales Market Share by Type in 2016
Table United States Antivenom Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antivenom Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antivenom by Type (2012-2017)
Figure Revenue Market Share of Antivenom by Type in 2016
Table United States Antivenom Price (USD/Dose) by Types (2012-2017)
Figure United States Antivenom Sales Growth Rate by Type (2012-2017)
Table United States Antivenom Sales (K Doses) by Application (2012-2017)
Table United States Antivenom Sales Market Share by Application (2012-2017)
Figure United States Antivenom Sales Market Share by Application (2012-2017)
Figure United States Antivenom Sales Market Share by Application in 2016
Table United States Antivenom Sales Growth Rate by Application (2012-2017)
Figure United States Antivenom Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merck Antivenom Sales Growth Rate (2012-2017)
Figure Merck Antivenom Sales Market Share in United States (2012-2017)
Figure Merck Antivenom Revenue Market Share in United States (2012-2017)
Table Summerland Serums (AU) Basic Information List
Table Summerland Serums (AU) Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Summerland Serums (AU) Antivenom Sales Growth Rate (2012-2017)
Figure Summerland Serums (AU) Antivenom Sales Market Share in United States (2012-2017)
Figure Summerland Serums (AU) Antivenom Revenue Market Share in United States (2012-2017)
Table Haffkine Bio Pharmaceutical Basic Information List
Table Haffkine Bio Pharmaceutical Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Haffkine Bio Pharmaceutical Antivenom Sales Growth Rate (2012-2017)
Figure Haffkine Bio Pharmaceutical Antivenom Sales Market Share in United States (2012-2017)
Figure Haffkine Bio Pharmaceutical Antivenom Revenue Market Share in United States (2012-2017)
Table MicroPharm Basic Information List
Table MicroPharm Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure MicroPharm Antivenom Sales Growth Rate (2012-2017)
Figure MicroPharm Antivenom Sales Market Share in United States (2012-2017)
Figure MicroPharm Antivenom Revenue Market Share in United States (2012-2017)
Table CSL (AU) Basic Information List
Table CSL (AU) Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CSL (AU) Antivenom Sales Growth Rate (2012-2017)
Figure CSL (AU) Antivenom Sales Market Share in United States (2012-2017)
Figure CSL (AU) Antivenom Revenue Market Share in United States (2012-2017)
Table SAVP Basic Information List
Table SAVP Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure SAVP Antivenom Sales Growth Rate (2012-2017)
Figure SAVP Antivenom Sales Market Share in United States (2012-2017)
Figure SAVP Antivenom Revenue Market Share in United States (2012-2017)
Table Flynn Pharma Basic Information List
Table Flynn Pharma Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Flynn Pharma Antivenom Sales Growth Rate (2012-2017)
Figure Flynn Pharma Antivenom Sales Market Share in United States (2012-2017)
Figure Flynn Pharma Antivenom Revenue Market Share in United States (2012-2017)
Table Serum Basic Information List
Table Serum Antivenom Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Serum Antivenom Sales Growth Rate (2012-2017)
Figure Serum Antivenom Sales Market Share in United States (2012-2017)
Figure Serum Antivenom Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antivenom
Figure Manufacturing Process Analysis of Antivenom
Figure Antivenom Industrial Chain Analysis
Table Raw Materials Sources of Antivenom Major Players/Suppliers in 2016
Table Major Buyers of Antivenom
Table Distributors/Traders List
Figure United States Antivenom Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Antivenom Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antivenom Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Antivenom Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Antivenom Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Antivenom Sales Volume (K Doses) Forecast by Type in 2022
Table United States Antivenom Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Antivenom Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Antivenom Sales Volume (K Doses) Forecast by Application in 2022
Table United States Antivenom Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Antivenom Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antivenom Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antivenom Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources